In a healthy parturient, the main causes of cardiac arrest are pulmonary embolism (PE) (19%), hemorrhage (17%), pregnancy-induced hypertension (16%), and infection/sepsis (13%).^[@R1]^ We present a maternal cardiac arrest caused by a massive PE, complicated by disseminated intravascular coagulation (DIC) at elective cesarean delivery. Point- of-care coagulation testing and intraoperative transesophageal echocardiography (TEE) aided successful resuscitation. The case report was reviewed with the patient and she provided written permission for its publication.

CASE DESCRIPTION
================

A 45-year-old (gravidity 5, parity 2) woman with a body mass index of 24 kg/m^2^ was admitted because of major placenta previa and antepartum hemorrhage. Apart from 2 previous uneventful spontaneous vaginal deliveries, she had no remarkable medical history. Ten days after admission at 37 + 1 weeks of gestation, she was scheduled for an elective lower segment cesarean delivery because of continued antepartum hemorrhage and a transverse lie.

The patient consented to a combined spinal-epidural (CSE) block. Two 16-gauge peripheral intravenous (IV) cannulas were placed, and electrocardiogram, noninvasive blood pressure, and oxygen saturation monitoring were established before the block. Initial blood pressure was 120/80 mm Hg, heart rate 105/min, and peripheral oxygen saturations (Sp[o]{.smallcaps}~2~) 96%. An uncomplicated CSE was performed with 11.5 mg 0.5% hyperbaric bupivacaine and 15 µg fentanyl. After the CSE, a sensory block to T4 bilaterally was confirmed with a Bromage score of 3. Blood pressure remained stable at 120/75 mm Hg supported by a phenylephrine infusion of 2 mg/h. Heart rate varied between 90 and 120/min and Sp[o]{.smallcaps}~2~ were 96%. After delivery of a live infant (Apgar score 9 at 1 and 5 minutes), the patient complained of nausea and dizziness, followed immediately by bradycardia of 35/min and loss of consciousness. Blood pressure was 70/35 mm Hg. Atropine 600 µg IV was administered to treat the bradycardia and succinylcholine 100 mg to facilitate immediate endotracheal intubation. After intubation, a carotid pulse was absent despite the electrocardiogram demonstrating a sinus rhythm of 100/min and pulseless electrical activity was diagnosed. As per the Australian Resuscitation Council guidelines, cardiopulmonary resuscitation commenced, epinephrine 1 mg was administered IV immediately and after every other pulse check. After endotracheal intubation, chest compressions with asynchronous ventilation were continued. Capnography confirmed endotracheal intubation and effective chest compressions. The lungs were ventilated with 100% oxygen in volume-controlled mode. The obstetricians delivered the placenta, exteriorized the uterus, and monitored effectiveness of thoracic compressions by continuous aortic palpation.

Return of spontaneous circulation (ROSC) occurred after 9 minutes. However, the patient suffered 2 further episodes of pulseless electrical activity (sinus rhythm, 140/min), each requiring chest compressions, lasting for approximately 5 minutes and occurring 10 minutes apart. A TEE performed during resuscitation demonstrated a dilated right ventricle (RV) with severely reduced systolic function. The left ventricle (LV) was underfilled with moderate globally reduced systolic function. At 30 minutes, there was relative hemodynamic stability supported by a noradrenaline infusion at 40 µg/min. A well-defined mass was identified in the right pulmonary artery during a detailed TEE examination (Figure [1](#F1){ref-type="fig"}).

![Transesophageal echocardiography demonstrating a right pulmonary artery mass. Midesophageal ascending aortic short-axis view. A indicates aorta; PE, pulmonary embolus; RPA, right pulmonary artery; SVC, superior vena cava.](acc-10-139-g001){#F1}

Two abdominal drains, a prophylactic Bakri intrauterine balloon, and vaginal packs were inserted, and the abdomen was closed. However, within 10 minutes of ROSC, bleeding from the vagina, oropharynx, and peripheral access sites occurred. A massive hemorrhage was declared and our institutional massive transfusion protocol was activated. Initial arterial blood gas analysis demonstrated a lactic acidosis and anemia (Table). Before performing rotational thromboelastometry (ROTEM), 2 units of packed red blood cells and 6 units of fresh frozen plasma were administered. In our institution, our ROTEM (Tem International, Munich, Germany) Delta testing module is located in the blood bank and the treating clinician interprets the results.

###### 

Serial ROTEM, Coagulation, and Arterial Blood Gas Results After Maternal Cardiac Arrest
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![Initial rotational thromboelastometry result at the onset of bleeding.](acc-10-139-g003){#F2}

The initial fibrin formation and polymerization (FIBTEM A5; amplitude at 5 minutes) of 7 mm indicated significant hypofibrinogenemia (Table). The extrinsic coagulation pathway (EXTEM) clotting time was within normal limits. Progression of the ROTEM trace showed narrowing at 12 minutes and the EXTEM and FIBTEM maximum lysis were \>15%. A value of 100% of maximum clot firmness at \<20 minutes demonstrated hyperfibrinolysis (Figure [2](#F2){ref-type="fig"}; Table). Corresponding laboratory blood investigations 30 minutes later confirmed hypofibrinogenemia (Table) and correlated with our suspicions of DIC.

PULMONARY EMBOLISM
==================

As per our critical bleeding ROTEM algorithm, EXTEM A10 of 23 mm (range, 43--65 mm) in combination with FIBTEM A10 \<12 mm indicated the need for platelet and fibrinogen administration and maximum lysis 100% indicated the need for tranexamic acid. Following these results, the patient received 3 g fibrinogen concentrate, 2 units of platelets, 8 units of cryoprecipitate, and 1 g of tranexamic acid. Our institutional protocol did not call for the off-label use of recombinant activated factor VIIa.

Under TEE-guided volume resuscitation, 2 L of balanced electrolyte solution and 1.5 L of 4% albumin were administered. Two doses of 10 mL of 10% calcium gluconate were administered prophylactically during resuscitation.

An hour later, ROTEM showed improvement. However, reduced FIBTEM A5 of 6 mm indicated continued hypofibrinogenemia (Table). Guided by these results, another 3 g of fibrinogen concentrate was administered.

Two hours after the initial arrest, the uterus contracted, core temperature was 35.5°C, and hemodynamic stability maintained with a noradrenaline infusion at 17 µg/min and the patient was transferred to the intensive care unit. After consultation of cardiologists and cardiac surgeons, plans were made to transfer the patient to the nearby cardiothoracic center for potential extracorporeal membrane oxygenation and surgical pulmonary embolectomy.

A transthoracic echocardiography performed in the intensive care unit demonstrated improved LV contractility (ejection fraction 0.55--0.60), with a severely dilated RV and impaired systolic function. There was mild pulmonary hypertension (RV systolic pressure 32 mm Hg, range 12--16 mm Hg). Milrinone was commenced to support RV contractility and decrease pulmonary vascular resistance and vasopressin to support systemic vasoconstriction. Further ROTEM results revealed improvements in the coagulopathy (Table); however, there was ongoing uterine bleeding with a further decrease in hemoglobin to 59 g/L (range, 115--161 g/L; Table). Because of the continuing uterine bleeding, anemia, and the planned transfer of the patient to a hospital without obstetric facilities, the patient underwent a hysterectomy. This occurred 4 hours after the initial arrest with further 4 units of packed red blood cells being administered. No further coagulation correction was required, because ROTEM had normalized (Figure [3](#F3){ref-type="fig"}; Table) and clinically the coagulopathy had resolved.

![Rotational thromboelastometry results during emergency hysterectomy.](acc-10-139-g004){#F3}

Following hysterectomy, formal laboratory tests confirmed a resolved coagulopathy with stabilized hemoglobin concentration (Table) and the interhospital transfer occurred. Further interventions were not necessary because the patient stabilized and was extubated the following day.

A computerized tomography pulmonary angiogram (Figure [4](#F4){ref-type="fig"}) performed following extubation demonstrated a saddle embolus extending into the segmental branches of the upper and middle lobes. Ultrasound of the lower limbs excluded deep venous thrombosis. Abdominal ultrasound investigation suggested a possible right ovarian thrombosis.

![Computerized tomography pulmonary angiogram demonstrating a large saddle pulmonary embolus (PE). Axial and sagittal views.](acc-10-139-g005){#F4}

The patient was discharged home 3 weeks after the cesarean delivery for continued outpatient care. A repeat transthoracic echocardiography demonstrated a normal LV size with low normal systolic function, ejection fraction 0.54, and a normal RV with low normal systolic function. The patient had no significant neurophysiological deficits and formal neuropsychology review revealed intact cognition. She continued to be on anticoagulation treatment under the guidance of the hematologists.

DISCUSSION
==========

Thrombosis and thromboembolism remains the leading cause of direct maternal death (11% maternal mortality).^[@R1],[@R2]^ Massive pulmonary thromboembolism constitutes 10% of all presentations of venous thromboembolism.^[@R3]^

Sudden maternal cardiopulmonary collapse followed by coagulopathy is often attributed to amniotic fluid embolism.^[@R4]^ TEE findings after ROSC suggested a massive PE, confirmed in the subsequent computerized tomography pulmonary angiogram. We hypothesize that a thrombosis of the proximal veins in the pelvis was dislodged at the time of delivery of the baby.

This patient had multiple antepartum risk factors for thromboembolism, including advanced maternal age,^[@R5],[@R6]^ parity,^[@R5],[@R6]^ antepartum hemorrhage,^[@R6]^ and hospitalization for nondelivery reasons for \>3 days.^[@R7]^ Prophylactic anticoagulation was withheld due to ongoing antepartum hemorrhage, known placenta previa, and the potential for emergent delivery.

DIC after massive PE has been reported in both obstetric and nonobstetric patients.^[@R8]--[@R10]^ Up to 9% of patients who suffer a cardiopulmonary arrest secondary to a PE fulfill overt DIC criteria.^[@R11]^ It is proposed that the presence of a large PE results in insufficiently contained thrombin generation at the clot surface causing an overflow of active coagulation factors into the systemic circulation. Hyperfibrinolysis has also been demonstrated using ROTEM after presumed amniotic fluid embolism.^[@R12]^

ROTEM is a point-of-care test of coagulation, used in trauma, maternity, hepatic, and cardiac surgery.^[@R13]^ It rapidly analyzes the entire process of coagulation, facilitating the targeted correction of coagulopathy. The standard panel comprises EXTEM, intrinsic coagulation pathway, and FIBTEM.

Using TEE during resuscitation facilitated the early diagnosis of the pulmonary arterial mass and guided fluid management. Coupled with ROTEM to select blood products, we avoided overtransfusion and RV strain.^[@R13]--[@R15]^ Early detection and aggressive correction of the hypofibrinogenemia was key to the successful management of the coagulopathy.

Obtaining a formal TEE during stabilization of the patient provided vital diagnostic information. Continuous consultation between our intensivists and the cardiothoracic center permitted patient transfer as soon as it was feasible.

This is the first published case report of maternal cardiac arrest with DIC successfully managed using ROTEM and TEE. This patient had a definitive diagnosis of a massive PE causing cardiopulmonary collapse with DIC during an elective cesarean delivery. Effective interdisciplinary communication was essential in our tertiary hospital, particularly because of the lack of an on-site cardiac surgery service. The use of TEE and ROTEM throughout resuscitation allowed targeted therapy and may well have contributed to the positive outcome.
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